These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33979683)

  • 21. p53 involvement in clonal hematopoiesis of indeterminate potential.
    Chen S; Liu Y
    Curr Opin Hematol; 2019 Jul; 26(4):235-240. PubMed ID: 31045645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of normal and malignant hematopoiesis.
    Rice KL; Hormaeche I; Licht JD
    Oncogene; 2007 Oct; 26(47):6697-714. PubMed ID: 17934479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics in normal and malignant hematopoiesis: An overview and update 2017.
    Goyama S; Kitamura T
    Cancer Sci; 2017 Apr; 108(4):553-562. PubMed ID: 28100030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.
    Desai P; Hassane D; Roboz GJ
    Best Pract Res Clin Haematol; 2019 Jun; 32(2):177-185. PubMed ID: 31203999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The cancer stem cell model in hematological malignancies].
    Nitta E; Iwama A
    Nihon Rinsho; 2015 May; 73(5):733-8. PubMed ID: 25985623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Proteomics of Biofluids in Haematological Malignancies.
    Dunphy K; O'Mahoney K; Dowling P; O'Gorman P; Bazou D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs in hematological malignancies.
    Lawrie CH
    Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
    Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
    Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of homeobox genes in normal hematopoiesis and hematological malignancies.
    van Oostveen J; Bijl J; Raaphorst F; Walboomers J; Meijer C
    Leukemia; 1999 Nov; 13(11):1675-90. PubMed ID: 10557039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
    Russkamp NF; Myburgh R; Kiefer JD; Neri D; Manz MG
    Exp Hematol; 2021 Mar; 95():31-45. PubMed ID: 33484750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of HDACs in normal and malignant hematopoiesis.
    Wang P; Wang Z; Liu J
    Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomics and the haematologist.
    Rees-Unwin KS; Morgan GJ; Davies FE
    Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the adaptor protein LNK in normal and malignant hematopoiesis.
    Gery S; Koeffler HP
    Oncogene; 2013 Jun; 32(26):3111-8. PubMed ID: 23045270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.
    Zamò A; Cecconi D
    J Proteomics; 2010 Jan; 73(3):508-20. PubMed ID: 19755177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnostics.
    Braziel RM; Shipp MA; Feldman AL; Espina V; Winters M; Jaffe ES; Petricoin EF; Liotta LA
    Hematology Am Soc Hematol Educ Program; 2003; ():279-93. PubMed ID: 14633786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis.
    Heuzé ML; Lamsoul I; Moog-Lutz C; Lutz PG
    Blood Cells Mol Dis; 2008; 40(2):200-10. PubMed ID: 17919948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The roles of microRNAs in hematopoiesis and hematopoietic malignancies].
    Li X; Zhang JH; Huang SA
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):489-90. PubMed ID: 17845765
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of the GATA2 transcription factor in normal and malignant hematopoiesis.
    Vicente C; Conchillo A; García-Sánchez MA; Odero MD
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):1-17. PubMed ID: 21605981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal evolution in hematological malignancies and therapeutic implications.
    Landau DA; Carter SL; Getz G; Wu CJ
    Leukemia; 2014 Jan; 28(1):34-43. PubMed ID: 23979521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNAs in normal and malignant hematopoiesis.
    Nobili L; Lionetti M; Neri A
    Oncotarget; 2016 Aug; 7(31):50666-50681. PubMed ID: 27177333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.